Cetera Investment Advisers Buys 166 Shares of CME Group Inc (NASDAQ:CME)

Cetera Investment Advisers grew its stake in shares of CME Group Inc (NASDAQ:CME) by 11.5% in the second quarter, according to the company in …

CME Group logoCetera Investment Advisers grew its stake in shares of CME Group Inc (NASDAQ:CME) by 11.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,613 shares of the financial services provider’s stock after acquiring an additional 166 shares during the period. Cetera Investment Advisers’ holdings in CME Group were worth $312,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of CME. Advantage Investment Management LLC grew its stake in shares of CME Group by 119.0% during the 2nd quarter. Advantage Investment Management LLC now owns 184 shares of the financial services provider’s stock valued at $36,000 after buying an additional 100 shares during the period. Westside Investment Management Inc. purchased a new stake in shares of CME Group during the 2nd quarter valued at $38,000. Close Asset Management Ltd purchased a new stake in shares of CME Group during the 1st quarter valued at $34,000. Permanens Capital L.P. purchased a new stake in shares of CME Group during the 1st quarter valued at $41,000. Finally, Patriot Financial Group Insurance Agency LLC boosted its position in CME Group by 209.4% during the 2nd quarter. Patriot Financial Group Insurance Agency LLC now owns 263 shares of the financial services provider’s stock worth $53,000 after purchasing an additional 178 shares during the period. Institutional investors own 84.99% of the company’s stock.

In other news, insider Sunil Cutinho sold 1,990 shares of the stock in a transaction on Tuesday, August 6th. The shares were sold at an average price of $202.38, for a total transaction of $402,736.20. Following the transaction, the insider now owns 31,182 shares in the company, valued at approximately $6,310,613.16. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO John W. Pietrowicz sold 2,500 shares of the stock in a transaction on Tuesday, July 9th. The stock was sold at an average price of $201.30, for a total transaction of $503,250.00. Following the transaction, the chief financial officer now owns 32,854 shares in the company, valued at approximately $6,613,510.20. The disclosure for this sale can be found here. Insiders have sold 59,626 shares of company stock valued at $12,255,934 over the last 90 days. 1.20% of the stock is currently owned by insiders.

Shares of CME Group stock traded up $0.42 on Friday, hitting $205.80. The company had a trading volume of 974,804 shares, compared to its average volume of 1,132,937. The business has a 50-day simple moving average of $211.25 and a 200-day simple moving average of $191.16. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.05 and a quick ratio of 1.05. The company has a market cap of $72.54 billion, a PE ratio of 30.18, a PEG ratio of 4.51 and a beta of 0.19. CME Group Inc has a 52 week low of $161.05 and a 52 week high of $224.91.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.75 by $0.01. The business had revenue of $1.27 billion during the quarter, compared to analysts’ expectations of $1.27 billion. CME Group had a net margin of 39.36% and a return on equity of 9.14%. The business’s revenue was up 20.1% on a year-over-year basis. During the same period last year, the firm posted $1.74 earnings per share. On average, equities research analysts predict that CME Group Inc will post 6.69 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Tuesday, September 10th will be issued a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a yield of 1.46%. The ex-dividend date is Monday, September 9th. CME Group’s payout ratio is 43.99%.

CME has been the subject of a number of research reports. Wells Fargo & Co upped their price target on shares of CME Group from $176.00 to $200.00 and gave the stock a “market perform” rating in a research report on Wednesday, July 3rd. BidaskClub cut shares of CME Group from a “buy” rating to a “hold” rating in a research report on Thursday. Deutsche Bank boosted their price objective on shares of CME Group from $224.00 to $240.00 and gave the stock a “buy” rating in a report on Friday, August 9th. Barclays boosted their price objective on shares of CME Group from $191.00 to $197.00 and gave the stock an “overweight” rating in a report on Thursday, May 23rd. Finally, Zacks Investment Research lowered shares of CME Group from a “hold” rating to a “sell” rating and set a $158.00 price objective on the stock. in a report on Monday, May 27th. Three investment analysts have rated the stock with a sell rating, six have given a hold rating and seven have given a buy rating to the stock. CME Group currently has an average rating of “Hold” and a consensus price target of $196.85.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Read More: How to trade the most active stocks

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

CME Group Inc. (NASDAQ:CME) Analyst’s Long Term Pick As Shares Moved 9.40% This Year

Shaers of CME Group Inc. (NASDAQ:CME) have been recommended as a long term growth pick. With the firm’s stock price currently trading around …

Shaers of CME Group Inc. (NASDAQ:CME) have been recommended as a long term growth pick. With the firm’s stock price currently trading around $205.80, the firm has proven a solid track record of growth over the recent years. Investors might consider the stock as a long term growth candidate as the firm has yielded 14.30% earnings per share growth over the past 5 years and 8.00% revenue growth over that same time frame.

Investors studying the fundamentals might be conducting in-depth company research before deciding when to purchase a particular stock. The investor checklist may include studying the scope of a company’s competitive industry advantage, examining company management, and trying to get a general feel if the stock is valued properly. Once the decision is made that the company is a good fit for the portfolio, it may be wise to assess whether or not current conditions and price levels indicate proper levels for share purchase. The timing of purchasing a researched stock obviously comes with some level of trepidation. Investors will only know in the future whether they got in at the right price. A stock that looks very attractive today may not be as attractive in the future. Sometimes the investor will just have to trust their research and instinct when purchasing shares.

Long-term growth (LTG) is an investing strategy where a stock will (hopefully) grow in value for a relatively long period of time. Long-term growth should be considered to be a relative term, due to different styles and goals of investors, but the endgame is the same.

A “buy-and-hold” investor will consider long-term growth as a longer time period then a day trader will. The buy-and-hold strategy looks ahead farther into the future, giving short-term price swings less consideration as long as the fundamentals stay the same. A trader is looking more closely at a weekly, or shorter, time frame and is more interested in immediate price fluctuations.

Let’s take a look at how the stock has been performing recently. Over the past twelve months, CME Group Inc. (NASDAQ:CME)’s stock was 9.40%. Over the last week of the month, it was -7.74%, 4.41% over the last quarter, and 20.96% for the past six months.

Over the past 50 days, CME Group Inc.’s stock is -8.50% off of the high and 6.58% removed from the low. Their 52-Week High and Low are as follows: -8.50% (High), 27.79%, (Low).

Despite the past success, investors want to know where the stock is headed from here. Analysts covering the shares have a consensus short-term price target of $208.87 on the equity. Analysts have a consensus recommendation of 2.50 based on a 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.

From time to time, investors may need to decide when to sell a winner. This can be one of the tougher portfolio decisions to make. When a winning stock keeps rising, it can be tough to part with it. Investors may become hesitant to sell because they don’t want to miss out on greater profits in the future. Sometimes this strategy will work, and other times investors may be watching all previous gains evaporate. Being able to sell a winner can provide obvious profits, and it may even be a confidence booster for the average investor. On the flip side, investors may also be faced with the decision of when to sell a loser. Even the most researched trades can go sour. Being able to detach from the trade mentally can end up saving the investor more grief down the line. Holding onto a stock with the hopes of a giant turnaround can be a recipe for portfolio disaster. Being able to cut losses is just as much a part of the process as being able to cash in winners. Learning from mistakes and being able to wipe the slate clean can help the investor be better prepared for future endeavors in the markets.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Market Tracker: Following Shares of CME Group Inc (CME.IX)

Watching the signals for CME Group Inc (CME.IX), we have noted that the Chaikin Oscillator is below zero. Traders may be watching for possible …

Watching the signals for CME Group Inc (CME.IX), we have noted that the Chaikin Oscillator is below zero. Traders may be watching for possible bearish momentum on the stock.

Investors constantly have to weigh risk against reward when trying to extract profits and maximum value from the stock market. Making educated investment decisions typically requires dedication, rational thinking, and self-control. Once the individual investor starts developing good habits, they can start to eliminate the bad ones that may be costing them enormous amounts of hard earned money. Everybody is prone to make mistakes at some point, and being able to realize what contributed to the mistake can help with corrective actions. Repeating the same mistakes over and over again in the stock market will most likely lead the investor down the wrong path.

The Average Directional Index or ADX is technical analysis indicator used to discern if a market is trending or not trending. The ADX alone measures trend strength but not direction. Using the ADX with the Plus Directional Indicator (+DI) and Minus Directional Indicator (-DI) may help determine the direction of the trend as well as the overall momentum. Many traders will use the ADX alongside other indicators in order to help spot proper trading entry/exit points. Currently, the 14-day ADX for CME Group Inc (CME.IX) is 26.47. Generally speaking, an ADX value from 0-25 would indicate an absent or weak trend. A value of 25-50 would indicate a strong trend. A value of 50-75 would signal a very strong trend, and a value of 75-100 would indicate an extremely strong trend.

When applying indicators for technical analysis, traders and investors might want to look at the ATR or Average True Range. The current 14-day ATR for CME Group Inc (CME.IX) is currently sitting at 4.36. The ATR basically measures the volatility of a stock on a day-to-day basis. The average true range is typically based on 14 periods and may be calculated daily, weekly, monthly, or intraday. The ATR is not considered a directional indicator, but it may reflect the strength of a particular move.

When performing stock analysis, investors and traders may opt to view technical levels. CME Group Inc (CME.IX) presently has a 14-day Commodity Channel Index (CCI) of -125.19. Investors and traders may use this indicator to help spot price reversals, price extremes, and the strength of a trend. Many investors will use the CCI in conjunction with other indicators when evaluating a trade. The CCI may be used to spot if a stock is entering overbought (+100) and oversold (-100) territory.

Shares of CME Group Inc (CME.IX) have a 200-day moving average of 188.59. The 50-day is 208.65, and the 7-day is sitting at 211.24. Using a bigger time frame to assess the moving average such as the 200-day, may help block out the noise and chaos that is often caused by daily price fluctuations. In some cases, MA’s may be used as strong reference points for spotting support and resistance levels.

Checking in on some other technical levels, the 14-day RSI is currently at 41.63, the 7-day stands at 33.06, and the 3-day is sitting at 30.41. Many investors look to the Relative Strength Index (RSI) reading of a particular stock to help identify overbought/oversold conditions. The RSI was developed by J. Welles Wilder in the late 1970’s. Wilder laid out the foundation for future technical analysts to further investigate the RSI and its relationship to underlying price movements. Since its inception, RSI has remained very popular with traders and investors. Other technical analysts have built upon the work of Wilder. The 14-day RSI is still a widely popular choice among technical stock analysts.

Following a pre-defined trading system might be a solid choice for securing profits in the stock market. Defining goals before creating a plan can be a good way to start the trader off on the right path. There are bound to be many ups and downs throughout the trading process. Being able to manage wins and losses may be one of the most important factors to becoming a successful trader. Without a researched plan, traders may realize how quick the losses can pile up. Properly managing risk, position size, entry and exit points, and stops, may come with experience, but it is typically necessary in order to stay above water in the fast paced market environment.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

CME Group Inc (NASDAQ:CME) Position Decreased by FineMark National Bank & Trust

FineMark National Bank & Trust decreased its position in CME Group Inc (NASDAQ:CME) by 9.8% during the 2nd quarter, according to the company …

CME Group logoFineMark National Bank & Trust decreased its position in CME Group Inc (NASDAQ:CME) by 9.8% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 29,168 shares of the financial services provider’s stock after selling 3,181 shares during the period. FineMark National Bank & Trust’s holdings in CME Group were worth $5,662,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of the company. Parnassus Investments CA purchased a new stake in CME Group during the second quarter worth about $544,292,000. Janus Henderson Group PLC boosted its holdings in CME Group by 10.7% during the first quarter. Janus Henderson Group PLC now owns 6,229,661 shares of the financial services provider’s stock worth $1,025,278,000 after buying an additional 603,645 shares in the last quarter. Geode Capital Management LLC boosted its holdings in CME Group by 12.9% during the fourth quarter. Geode Capital Management LLC now owns 4,715,269 shares of the financial services provider’s stock worth $885,776,000 after buying an additional 537,917 shares in the last quarter. FMR LLC boosted its holdings in CME Group by 5.7% during the first quarter. FMR LLC now owns 6,553,654 shares of the financial services provider’s stock worth $1,078,600,000 after buying an additional 355,566 shares in the last quarter. Finally, AKO Capital LLP boosted its holdings in CME Group by 54.6% during the second quarter. AKO Capital LLP now owns 935,264 shares of the financial services provider’s stock worth $181,544,000 after buying an additional 330,305 shares in the last quarter. 84.99% of the stock is currently owned by institutional investors and hedge funds.

In other news, CEO Terrence A. Duffy sold 35,000 shares of the stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $200.15, for a total value of $7,005,250.00. Following the completion of the sale, the chief executive officer now owns 79,057 shares of the company’s stock, valued at $15,823,258.55. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO John W. Pietrowicz sold 2,500 shares of the stock in a transaction on Tuesday, July 9th. The stock was sold at an average price of $201.30, for a total transaction of $503,250.00. Following the completion of the sale, the chief financial officer now directly owns 32,854 shares of the company’s stock, valued at approximately $6,613,510.20. The disclosure for this sale can be found here. Insiders have sold 59,626 shares of company stock valued at $12,255,934 in the last ninety days. 1.20% of the stock is currently owned by company insiders.

CME has been the topic of a number of research analyst reports. UBS Group boosted their price objective on shares of CME Group from $191.00 to $214.00 and gave the stock a “neutral” rating in a report on Thursday, September 5th. Zacks Investment Research downgraded shares of CME Group from a “hold” rating to a “sell” rating and set a $158.00 price target on the stock. in a report on Monday, May 27th. Barclays upped their price target on shares of CME Group from $191.00 to $197.00 and gave the company an “overweight” rating in a report on Thursday, May 23rd. BidaskClub downgraded shares of CME Group from a “buy” rating to a “hold” rating in a report on Thursday. Finally, Wells Fargo & Co upped their price target on shares of CME Group from $176.00 to $200.00 and gave the company a “market perform” rating in a report on Wednesday, July 3rd. Three analysts have rated the stock with a sell rating, six have assigned a hold rating and seven have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $196.85.

Shares of NASDAQ:CME traded up $0.42 during trading on Friday, reaching $205.80. The stock had a trading volume of 974,804 shares, compared to its average volume of 1,132,937. CME Group Inc has a fifty-two week low of $161.05 and a fifty-two week high of $224.91. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.15. The business has a fifty day moving average price of $211.25 and a 200-day moving average price of $191.16. The stock has a market cap of $72.54 billion, a P/E ratio of 30.18, a PEG ratio of 4.51 and a beta of 0.19.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.76 EPS for the quarter, topping the consensus estimate of $1.75 by $0.01. CME Group had a net margin of 39.36% and a return on equity of 9.14%. The firm had revenue of $1.27 billion during the quarter, compared to analyst estimates of $1.27 billion. During the same quarter in the prior year, the business posted $1.74 earnings per share. CME Group’s revenue for the quarter was up 20.1% compared to the same quarter last year. As a group, equities analysts forecast that CME Group Inc will post 6.69 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Tuesday, September 10th will be given a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a yield of 1.46%. The ex-dividend date is Monday, September 9th. CME Group’s dividend payout ratio (DPR) is 43.99%.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Further Reading: What causes a yield curve to invert?

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

CME Group (NASDAQ:CME) Given New $214.00 Price Target at UBS Group

CME Group (NASDAQ:CME) had its price objective increased by UBS Group from $191.00 to $214.00 in a report issued on Thursday, September 5th, …

CME Group Inc logoCME Group (NASDAQ:CME) had its price objective increased by UBS Group from $191.00 to $214.00 in a report issued on Thursday, September 5th, BenzingaRatingsTable reports. The brokerage currently has a neutral rating on the financial services provider’s stock.

A number of other research analysts also recently commented on CME. Wells Fargo & Co increased their price objective on CME Group from $176.00 to $200.00 and gave the company a market perform rating in a report on Wednesday, July 3rd. Zacks Investment Research downgraded CME Group from a hold rating to a sell rating and set a $158.00 price objective on the stock. in a report on Monday, May 27th. ValuEngine upgraded CME Group from a hold rating to a buy rating in a report on Wednesday, May 8th. Deutsche Bank increased their price objective on CME Group from $224.00 to $240.00 and gave the company a buy rating in a report on Friday, August 9th. Finally, BidaskClub upgraded CME Group from a hold rating to a buy rating in a report on Friday, August 9th. Three analysts have rated the stock with a sell rating, six have issued a hold rating and seven have given a buy rating to the stock. The company currently has a consensus rating of Hold and a consensus price target of $196.85.

CME traded up $0.42 during mid-day trading on Thursday, hitting $205.80. 974,804 shares of the stock were exchanged, compared to its average volume of 1,132,937. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 0.15. The company has a market cap of $72.54 billion, a PE ratio of 30.18, a PEG ratio of 4.51 and a beta of 0.19. The firm’s fifty day moving average is $211.25 and its two-hundred day moving average is $191.16. CME Group has a 1-year low of $161.05 and a 1-year high of $224.91.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.75 by $0.01. CME Group had a return on equity of 9.14% and a net margin of 39.36%. The company had revenue of $1.27 billion for the quarter, compared to analyst estimates of $1.27 billion. During the same quarter last year, the company earned $1.74 EPS. CME Group’s revenue for the quarter was up 20.1% compared to the same quarter last year. As a group, research analysts anticipate that CME Group will post 6.69 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Stockholders of record on Tuesday, September 10th will be issued a $0.75 dividend. The ex-dividend date of this dividend is Monday, September 9th. This represents a $3.00 annualized dividend and a dividend yield of 1.46%. CME Group’s dividend payout ratio is currently 43.99%.

In related news, CEO Terrence A. Duffy sold 35,000 shares of CME Group stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $200.15, for a total transaction of $7,005,250.00. Following the completion of the transaction, the chief executive officer now directly owns 79,057 shares of the company’s stock, valued at $15,823,258.55. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CFO John W. Pietrowicz sold 2,500 shares of CME Group stock in a transaction on Tuesday, July 9th. The stock was sold at an average price of $201.30, for a total value of $503,250.00. Following the transaction, the chief financial officer now directly owns 32,854 shares of the company’s stock, valued at $6,613,510.20. The disclosure for this sale can be found here. Insiders sold a total of 59,626 shares of company stock valued at $12,255,934 over the last three months. Insiders own 1.20% of the company’s stock.

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Advantage Investment Management LLC increased its stake in shares of CME Group by 119.0% in the second quarter. Advantage Investment Management LLC now owns 184 shares of the financial services provider’s stock worth $36,000 after acquiring an additional 100 shares during the last quarter. Westside Investment Management Inc. acquired a new stake in shares of CME Group in the second quarter valued at approximately $38,000. Close Asset Management Ltd acquired a new stake in CME Group during the 1st quarter worth $34,000. Private Capital Group LLC boosted its position in shares of CME Group by 44.9% during the second quarter. Private Capital Group LLC now owns 242 shares of the financial services provider’s stock worth $40,000 after purchasing an additional 75 shares in the last quarter. Finally, Permanens Capital L.P. bought a new stake in CME Group in the 1st quarter valued at $41,000. Hedge funds and other institutional investors own 84.99% of the company’s stock.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Featured Story: How to calculate compound interest

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts